Publication Name	World Journal of Clinical Urology
Manuscript ID	10021
Country	United States

Received	2014-03-09 16:54
Peer-Review Started	2014-03-10 09:44
To Make the First Decision	2014-04-28 14:34
Return for Revision	2014-04-30 14:44
Revised	2014-06-12 23:36
Second Decision	2014-07-14 17:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-07-14 17:25
Articles in Press	2014-07-14 17:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-11-17 08:48
Publish the Manuscript Online	2014-11-19 17:43

ISSN	2219-2816 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Review
Article Title	Metabolic syndrome in the development and progression of prostate cancer
Manuscript Source	Invited Manuscript
All Author List	Andrew C Strine, Kevin R Rice and Timothy A Masterson
Funding Agency and Grant Number
Corresponding Author	Andrew C Strine, MD, Department of Urology, Indiana University School of Medicine, 535 N. Barnhill Drive, Suite 150, Indianapolis, IN 46202, United States. astrine@iupui.edu
Key Words	Diabetes mellitus; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Insulin resistance; Male; Metabolic syndrome X; Obesity; Prostatic neoplasms
Core Tip	The current literature is conflicted on the association between metabolic syndrome (MetS) and prostate cancer (PCa), although several studies have demonstrated that men with MetS or its individual components may have an increased risk of more aggressive disease and mortality as well as a poorer outcome after their treatment for PCa. These men may benefit from weight loss, physical activity, and the addition of medications like statins for preventing PCa and improving their outcomes after treatment. A majority of the existing evidence is retrospective or observational in nature, which underscores the need for more randomized controlled trials in the future.
Publish Date	2014-11-19 17:43
Citation	Strine AC, Rice KR, Masterson TA. Metabolic syndrome in the development and progression of prostate cancer. World J Clin Urol 2014; 3(3): 168-183
URL	http://www.wjgnet.com/2219-2816/full/v3/i3/168.htm
DOI	http://dx.doi.org/10.5410/wjcu.v3.i3.168

Full Article (PDF)	WJCU-3-168.pdf
Full Article (Word)	WJCU-3-168.doc
Manuscript File	10021-Review.docx
Answering Reviewers	10021-Answering reviewers.pdf
Copyright License Agreement	10021-Copyright assignment.pdf
Peer-review Report	10021-Peer review(s).pdf
Scientific Misconduct Check	10021-CrossCheck.jpg
Scientific Editor Work List	10021-Scientific editor work list.pdf